Celldex Therapeutics - 48 Year Dividend History | CLDX

Historical dividend payout and yield for Celldex Therapeutics (CLDX) since 1971. The current TTM dividend payout for Celldex Therapeutics (CLDX) as of April 25, 2019 is $0.00. The current dividend yield for Celldex Therapeutics as of April 25, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.047B $0.010B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.824B 12.37
Gilead Sciences (GILD) United States $80.063B 10.19
Bio-Techne Corp (TECH) United States $7.211B 48.58